Aspirin for prevention of colorectal cancer shows uncertain long-term benefit and increases bleeding risk, requiring individualized risk assessment for treatment decisions.

NEW ORLEANS -- People with diabetes may be among those who still benefit from primary prevention aspirin, a large observational study suggested. In contrast with the unimpressive track record of ...

Please provide your email address to receive an email when new articles are posted on . Up to 15% of older adults may routinely use aspirin for primary prevention. Many continue use despite knowing ...

Previous guidelines recommended low-dose aspirin therapy for the primary prevention of stroke in patients with type 1 or type 2 diabetes mellitus who were at increased cardiovascular (CV) risk. Risk ...

Following updated recommendations, there was a significant decrease in reported primary prevention aspirin use from 23.5% in 2017-2020 to 17.2% in 2021-2023. (HealthDay News) — Among older adults and ...

Risk of MACE down but brain bleeds up at 1 year after giant cell arteritis ...

22.7 percent of primary prevention aspirin users started aspirin without a physician's recommendation. (HealthDay News) — Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart Association (AHA)/American College of Cardiology (ACC) guidelines restricted ...